cancer (n=2), other thyroid disease (n=3) and non-thyroid tumor sites (n=2) were identified.
with benign thyroid diseases according to quality assessment criteria 54 -Measurement properties of GO-QOL and ThyTSQ are satisfactory in measuring 55 HRQOL in patients with graves' ophthalmopathy and hypothyroidism, respectively. Thyroid diseases such as thyroid dysfunctions and cancers occur not uncommonly in 75 the general population and have imposed an increased burden on our already over-stretched 76 healthcare system [1] [2] [3] . This increased burden is attributed to the increased incidence as well length version and tested for the correlations with the shortened version of the instrument.
172
Responsiveness was examined using different statistics to detect changes in the construct 173 being measured over time. property was synthesized by taking the quality ratings of each measurement study,
187
consistency of results between studies, and its evidence level for measurement properties.
188
One of the five possible rating options representing 'strong' (+++ or ---), 'moderate' (++ or -- 
